BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38378246)

  • 21. Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.
    Baum C; Weiss C; Gebhardt C; Utikal J; Marx A; Koenen W; Géraud C
    Int J Cancer; 2017 Apr; 140(8):1907-1917. PubMed ID: 27935036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis.
    Stassen RC; Maas CCHM; van der Veldt AAM; Lo SN; Saw RPM; Varey AHR; Scolyer RA; Long GV; Thompson JF; Rutkowski P; Keilholz U; van Akkooi ACJ; Verhoef C; van Klaveren D; Grünhagen DJ
    Lancet Oncol; 2024 Apr; 25(4):509-517. PubMed ID: 38547894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposal for the applicability of modified Breslow (measured from the basal membrane) as a predictor of survival and sentinel lymph node outcome in patients with cutaneous melanoma.
    Asato MA; Moares Neto FA; Moraes MPT; Ocanha-Xavier JP; Takita LC; Marques MEA; Xavier-Júnior JCC
    An Bras Dermatol; 2024; 99(3):398-406. PubMed ID: 38378363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges in sentinel node pathology in the era of adjuvant treatment.
    Franke V; Madu MF; Bierman C; Klop WMC; van Houdt WJ; Wouters MWJM; van de Wiel BA; van Akkooi ACJ
    J Surg Oncol; 2020 Oct; 122(5):964-972. PubMed ID: 32602119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sentinel node in melanoma and breast cancer. Current considerations].
    Vidal-Sicart S; Vilalta Solsona A; Alonso Vargas MI
    Rev Esp Med Nucl Imagen Mol; 2015; 34(1):30-44. PubMed ID: 25455506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node tumour burden using digital cell count estimation predicts outcomes in melanoma.
    Hartsough EM; Miller D; Shanley R; Domingo-Musibay E; Giubellino A
    Histopathology; 2022 May; 80(6):954-964. PubMed ID: 34402533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands.
    van den Broek FJ; Sloots PC; de Waard JW; Roumen RM
    Int J Clin Oncol; 2013 Jun; 18(3):428-34. PubMed ID: 22402887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time to reconsider the role of sentinel lymph node biopsy in melanoma.
    Bigby M; Zagarella S; Sladden M; Popescu CM
    J Am Acad Dermatol; 2019 Apr; 80(4):1168-1171. PubMed ID: 30471314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How morphometric analysis of metastatic load predicts the (un)usefulness of PET scanning: the case of lymph node staging in melanoma.
    Mijnhout GS; Hoekstra OS; van Lingen A; van Diest PJ; Adèr HJ; Lammertsma AA; Pijpers R; Meijer S; Teule GJ
    J Clin Pathol; 2003 Apr; 56(4):283-6. PubMed ID: 12663640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Touch Imprinting Cytology may be useful in the intraoperative evaluation of the sentinel lymph node in melanoma.
    Turoldo A; Pascuali A; Bortul M; Silvestri M; Dobrinja C; Zanconati F; di Meo N; Zalaudek I; De Manzini N
    Ann Ital Chir; 2019; 90():491-496. PubMed ID: 31929175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria.
    van der Ploeg AP; van Akkooi AC; Schmitz PI; Koljenovic S; Verhoef C; Eggermont AM
    Eur J Cancer; 2010 Sep; 46(13):2414-21. PubMed ID: 20621467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients.
    El Sharouni MA; Scolyer RA; van Gils CH; Ch'ng S; Nieweg OE; Pennington TE; Saw RP; Shannon K; Spillane A; Stretch J; Witkamp AJ; Sigurdsson V; Thompson JF; van Diest PJ; Lo SN
    Eur J Cancer; 2022 May; 167():133-141. PubMed ID: 35216870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing the prognostic role of melanoma sentinel lymph nodes through microscopic tumour burden characterization: clinical usefulness in patients who do not undergo complete lymph node dissection.
    Borgognoni L; Bellucci F; Urso C; Manneschi G; Gerlini G; Brandani P; Chiarugi C; Gelli R; Giannotti V; Sestini S
    Melanoma Res; 2019 Apr; 29(2):163-171. PubMed ID: 30778017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement.
    Dewar DJ; Newell B; Green MA; Topping AP; Powell BW; Cook MG
    J Clin Oncol; 2004 Aug; 22(16):3345-9. PubMed ID: 15310779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel Lymph Nodes in Cutaneous Melanoma.
    Prieto VG
    Clin Lab Med; 2017 Sep; 37(3):417-430. PubMed ID: 28802493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sentinel lymph nodes in cutaneous melanoma: the experience in the Florence area].
    Urso C; Borgognoni L; Vaggelli L; Giannini A; Salvadori A; Zini E; Reali UM
    Pathologica; 2003 Jun; 95(3):133-9. PubMed ID: 12968307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of tumor load in the sentinel node in melanoma: clinical dilemmas.
    van Akkooi AC; Verhoef C; Eggermont AM
    Nat Rev Clin Oncol; 2010 Aug; 7(8):446-54. PubMed ID: 20567244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.